Home
Disc Medicine, Inc.

Disc Medicine, Inc. Market Share Analysis for August 2026

DISC-0974 is an investigational anti-hemojuvelin (HJV) monoclonal antibody designed to suppress the production of hepcidin and enhance iron levels to treat anemia of inflammation.

Health > Biotechnology and Pharmaceuticals

Domaindiscmedicine.com

Year Founded2017

Employees51 - 200

Annual Revenue--

Disc Medicine, Inc.

Disc Medicine, Inc. (including company regionals)

discmedicine.com

See more website traffic and engagement information

Total visits to Disc Medicine, Inc.'s top domains

Understand Disc Medicine, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

discmedicine.com5.5K

See more with Sales Intelligence

Avg. visit duration in Disc Medicine, Inc.'s top domains

Analyze Disc Medicine, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

discmedicine.com00:00:14

See more with Sales Intelligence

Avg. pageviews on Disc Medicine, Inc.'s top domains

See how Disc Medicine, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

discmedicine.com1.77

See more with Sales Intelligence

Disc Medicine, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

viridiantherapeutics.comCompany NameViridian Therapeutics, Inc.Employees51 - 200HQUnited States, Massachusetts, WalthamAnnual revenue$50M - $75MTotal visits12.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Disc Medicine, Inc.

These are the website technologies, by industry, used by Disc Medicine, Inc. top domains

Payment & Currencies (11)

Cart Functionality

eCommerce (7)

OpenCart

Advertising (4)

Google Adsense

Widget (3)

Twemoji

More Technologies

9

See all

News & Signals from Disc Medicine, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDisc Medicine attended event Society of Hematologic Oncology (SOHO) Annual Meeting on Sep 9th '26.Disc Medicine, a clinical-stage biopharmaceutical company focused on hematologic diseases, announced it will share data from multiple programs in its pipeline at this year's Society of Hematologic Oncology (SOHO) Annual Meeting.

NewsDisc Medicine attended event SOHO Annual Meeting on Sep 9th '26.WATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) - Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple clinical programs, including an oral presentation of initial data from the RESTORE-PV trial of DISC-3405 in patients with polycythemia vera (PV), at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026.